Concord Biotech: Clarification Regarding Increase In Volume

With reference to the BSEs email L/SURV/ONL/PV/APJ/2025-26/908 dated February 09 2026 The Company hereby clarifies that the Company is in Compliance with Regulation 30 of SEBI (LODR) Regulations 2015 and has been promptly informing the stock exchanges on all events and information which have a bearing on operation or performance of Company. There is no undisclosed/price sensitive information or any impending announcement / corporate action which needs to be informed to the exchange at this point of time.